CCS’ Post

View organization page for CCS, graphic

13,898 followers

Today we unveiled PropheSee™, our AI-powered predictive model that drives CGM adherence for people living with diabetes. After two-plus years of development and involvement from virtually every function of the company, PropheSee™ is able to derive meaningful insights from multiple data sources and predict which patients are most likely to need therapy adherence support in the future. But it's what happens next that is game-changing. With those analytics and with those predictions, PropheSee™ delivers hyper-personalized interventions -- from custom messaging to relevant support -- to help prevent lapses in care. And patients have responded. Through rigorous testing, we’ve observed increases in CGM adherence rates of more than 50%. Needless to say, we're excited. Learn more at https://lnkd.in/epN48w_i #healthtech #chroniccare #diabetes #diabetesmanagement #ai #healthai #ahip2024

Predictive Analytics, Hyper-Personalized Interventions, Increased CGM Adherence

Predictive Analytics, Hyper-Personalized Interventions, Increased CGM Adherence

ccsmed.com

To view or add a comment, sign in

Explore topics